Mark Cuban, a billionaire investor, has tested a shipment of DNA-like molecules developed by California and Dutch researchers in his company Cost Plus Drugs. This move represents a shift from traditional generic drug production to a focus on rare disease treatments, aiming to help patients in unfortunate situations. The initiative could potentially provide cost-effective alternatives to expensive treatments, highlighting the evolving market for rare disease treatments.
Key points
Mark Cuban, a billionaire investor, has tested a shipment of DNA-like molecules developed…: Mark Cuban, a billionaire investor, has tested a shipment of DNA-like molecules developed by California and Dutch researchers in his company Cost Plus Drugs.
This move represents a shift from traditional generic drug production to a focus on rare…: This move represents a shift from traditional generic drug production to a focus on rare disease treatments.
The initiative aims to help patients in unfortunate situations.: The initiative aims to help patients in unfortunate situations.
Sources checked by our analysis pipeline: 1
Billionaire Mark Cuban has spent the last five years trying to make generic drugs like chemotherapy and antifungal ointment cheaper for Americans. But earlier this year, a very different type of medicine began arriving at his Dallas factory.
One shipment contained DNA-like molecules crafted by California chemists to patch the rare genetic mutation destroying a single patient’s neurons. Another carried DNA-like molecules developed with Dutch researchers to stop a rare disease that causes adults to progressively lose control of their muscles.
They are the first test of Cuban’s newest vision for his company Cost Plus Drugs: shake up the business of custom-made rare disease medicines. “It was an obvious chance for us to help those in that unfortunate situation,” he wrote in an email.
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.
The traditional method of communicating about measles vaccines and public health is ineffective, leading to a significant decline in vaccination rates and an increase in measles cases. Despite the serious health risks, many people remain unaware of the virus' dangers, and public health authorities are considering a new approach to build trust and encourage vaccination. This shift could help address the declining rates and reduce the number of measles cases.
The United States has seen its sixth measles-associated death this year, marking the return of the disease, which was previously eradicated in 2000. The return of measles is partly due to vaccine misinformation and political polarization, but it is also a result of a failure in America’s public health communication. The country’s communication methods, which tend to tell and not teach, have failed to persuade people to protect one another.
A woman has been awarded a bravery medal for her heroic actions after successfully reviving her boyfriend twice after being struck by lightning. The incident occurred in 2019, when the woman, now 27, was driving home from work when she was struck by lightning. Despite the shock and pain, she managed to revive her boyfriend, who was also struck by lightning. The couple was able to get to a hospital and receive treatment, but the woman's bravery was recognized when she was awarded a bravery medal. The incident has b…